Header Logo

Connection

Ross Abrams to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Ross Abrams has written about Treatment Outcome.
Ross Abrams
Connection Strength
0.830
Treatment Outcome
  1. Neoadjuvant Interdigitated Chemoradiotherapy Using Mesna, Doxorubicin, and Ifosfamide for Large, High-grade, Soft Tissue Sarcomas of the Extremity: Improved Efficacy and Reduced Toxicity. Am J Clin Oncol. 2019 01; 42(1):1-5.
    View in: PubMed
    Score: 0.090
  2. Radiotherapy for soft tissue sarcoma: 50 years of change and improvement. Am Soc Clin Oncol Educ Book. 2014; 244-51.
    View in: PubMed
    Score: 0.064
  3. Radiotherapy in the adjuvant management of pancreatic adenocarcinoma: is it helpful? Expert Rev Gastroenterol Hepatol. 2012 Apr; 6(2):149-61.
    View in: PubMed
    Score: 0.056
  4. Cholangiocarcinoma--what level of evidence should we have? Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):1-2.
    View in: PubMed
    Score: 0.045
  5. Management of a patient with borderline resectable pancreatic cancer. Case report and review. Oncology (Williston Park). 2008 Nov 30; 22(13):1524-9.
    View in: PubMed
    Score: 0.045
  6. Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum. Arch Surg. 2007 Mar; 142(3):285-8.
    View in: PubMed
    Score: 0.040
  7. Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC). Radiother Oncol. 2006 Nov; 81(2):163-7.
    View in: PubMed
    Score: 0.039
  8. Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003. Surg Oncol Clin N Am. 2004 Oct; 13(4):621-38, ix.
    View in: PubMed
    Score: 0.033
  9. Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 2003 Sep 01; 57(1):166-71.
    View in: PubMed
    Score: 0.031
  10. Adjuvant therapy for pancreatic adenocarcinoma: what have we learned since 1985? Int J Radiat Oncol Biol Phys. 2003; 56(4 Suppl):3-9.
    View in: PubMed
    Score: 0.030
  11. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol. 2002 May 01; 20(9):2267-76.
    View in: PubMed
    Score: 0.028
  12. Continuing controversy over adjuvant therapy of pancreatic cancer. Lancet. 2001 Nov 10; 358(9293):1565-6.
    View in: PubMed
    Score: 0.027
  13. Adjuvant therapy for pancreatic adenocarcinoma. J Gastrointest Surg. 2001 Jan-Feb; 5(1):6-7.
    View in: PubMed
    Score: 0.026
  14. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center. Cancer J Sci Am. 1998 May-Jun; 4(3):178-84.
    View in: PubMed
    Score: 0.021
  15. Influence of prognostic groupings and treatment results in the management of unresectable hepatoma: experience with Cisplatinum-based chemoradiotherapy in 76 patients. Int J Radiat Oncol Biol Phys. 1997 Dec 01; 39(5):1077-85.
    View in: PubMed
    Score: 0.021
  16. Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery. J Neurooncol. 2018 Jan; 136(2):289-298.
    View in: PubMed
    Score: 0.021
  17. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997 Sep; 226(3):248-57; discussion 257-60.
    View in: PubMed
    Score: 0.020
  18. ACR Appropriateness Criteria? Borderline and Unresectable Pancreas Cancer. Oncology (Williston Park). 2016 Jul; 30(7):619-24, 627, 632.
    View in: PubMed
    Score: 0.019
  19. ACR Appropriateness Criteria Radiologic Management of Hepatic Malignancy. J Am Coll Radiol. 2016 Mar; 13(3):265-73.
    View in: PubMed
    Score: 0.018
  20. Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas. Clin Cancer Res. 2015 Dec 15; 21(24):5612-8.
    View in: PubMed
    Score: 0.018
  21. Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial. Lancet Oncol. 2013 Apr; 14(4):317-26.
    View in: PubMed
    Score: 0.015
  22. Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients. J Thorac Oncol. 2011 Jun; 6(6):1079-86.
    View in: PubMed
    Score: 0.013
  23. Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial. Ann Surg Oncol. 2011 May; 18(5):1319-26.
    View in: PubMed
    Score: 0.013
  24. Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):985-91.
    View in: PubMed
    Score: 0.013
  25. Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial. Ann Surg Oncol. 2011 Feb; 18(2):337-44.
    View in: PubMed
    Score: 0.013
  26. Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer. Gastroenterology. 2009 Jan; 136(1):187-95.
    View in: PubMed
    Score: 0.011
  27. Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma. Biol Blood Marrow Transplant. 2005 Jan; 11(1):39-46.
    View in: PubMed
    Score: 0.009
  28. Adult patients with supratentorial pilocytic astrocytomas: a prospective multicenter clinical trial. Int J Radiat Oncol Biol Phys. 2004 Mar 15; 58(4):1153-60.
    View in: PubMed
    Score: 0.008
  29. Clinical research in pancreatic cancer: the Radiation Therapy Oncology Group trials. Int J Radiat Oncol Biol Phys. 2003; 56(4 Suppl):31-7.
    View in: PubMed
    Score: 0.007
  30. Long-term results of blood and marrow transplantation for Hodgkin's lymphoma. J Clin Oncol. 2001 Dec 01; 19(23):4314-21.
    View in: PubMed
    Score: 0.007
  31. Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphoma. Biol Blood Marrow Transplant. 2001; 7(10):561-7.
    View in: PubMed
    Score: 0.006
  32. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000 Nov-Dec; 4(6):567-79.
    View in: PubMed
    Score: 0.006
  33. Is there a role for surgical resection in the treatment of early-stage pancreatic lymphoma? J Am Coll Surg. 2000 Mar; 190(3):319-30.
    View in: PubMed
    Score: 0.006
  34. Should pancreaticoduodenectomy be performed in octogenarians? J Gastrointest Surg. 1998 May-Jun; 2(3):207-16.
    View in: PubMed
    Score: 0.005
  35. Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg. 1996 Jun; 223(6):718-25; discussion 725-8.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.